Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(121 sites)
United States
Highlands Oncology Group ( Site 2728), Springdale, Arkansas University of California San Diego Moores Cancer Center ( Site 2717), La Jolla, California Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724), Torrance, California Colorado Blood Cancer Institute ( Site 2726), Denver, Colorado The University of Louisville, James Graham Brown Cancer Center ( Site 2729), Louisville, Kentucky Mayo Clinic - Rochester ( Site 2706), Rochester, Minnesota Astera Cancer Care ( Site 2732), East Brunswick, New Jersey John Theurer Cancer Center at Hackensack University Medical Center ( Site 2704), Hackensack, New Jersey Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 2708), Fargo, North Dakota UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas, Texas Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane, Washington Argentina
Hospital Aleman ( Site 0102), Ciudad Autonoma de Buenos Aires, Buenos Aires Centro de Educación Médica e Investigaciones Clínicas (CEMIC) ( Site 0103), Buenos Aires, Buenos Aires F.D. Fundacion Estudios Clinicos ( Site 0112), Rosario, Santa Fe Province FUNDALEU ( Site 0104), Caba Hospital Privado Universitario de Córdoba ( Site 0107), Córdoba Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0110), Mendoza Australia
Nepean Hospital-Nepean Cancer Care Centre ( Site 0204), Sydney, New South Wales Box Hill Hospital ( Site 0203), Box Hill, Victoria Sir Charles Gairdner Hospital ( Site 0200), Nedlands, Western Australia Brazil
Hospital das Clinicas FMUSP-Pesquisa Clínica Hematologia ( Site 0303), São Paulo, São Paulo Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0300), Rio de Janeiro BP - A Beneficencia Portuguesa de São Paulo ( Site 0302), São Paulo Hospital Paulistano - Amil Clinical Research ( Site 0311), São Paulo Canada
Arthur J.E. Child Comprehensive Cancer Centre ( Site 0401), Calgary, Alberta The Ottawa Hospital ( Site 0404), Ottawa, Ontario Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0406), Toronto, Ontario CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0403), Montreal, Quebec Jewish General Hospital ( Site 0400), Montreal, Quebec China
Anhui Provincial Hospital ( Site 2808), Hefei, Anhui Peking University Third Hospital-Hematology ( Site 2827), Beijing, Beijing Municipality The Second Affiliated Hospital of Chongqing Medical University ( Site 2825), Chongqing, Chongqing Municipality Sun Yat-sen University Cancer Center-Internal Medicine ( Site 2824), Guangzhou, Guangdong Liuzhou People's Hospital ( Site 2817), Liuchow, Guangxi Guangxi Medical University Cancer Hospital ( Site 2814), Nanning, Guangxi Henan Cancer Hospital-hematology department ( Site 2802), Zhengzhou, Henan Wuhan Union Hospital ( Site 2816), Wuhan, Hubei The Second Xiangya Hospital of Central South University ( Site 2820), Changsha, Hunan Hunan Cancer Hospital ( Site 2822), Changsha, Hunan Jiangsu Province Hospital ( Site 2823), Nanjing, Jiangsu The Affiliated Hospital of Xuzhou Medical College ( Site 2818), Xuzhou, Jiangsu Czechia
Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0600), Brno, Brno-mesto Fakultni nemocnice Hradec Kralove ( Site 0601), Hradec Králové Denmark
Aarhus University Hospital ( Site 0702), Aarhus N, Central Jutland Aalborg Universitetshospital ( Site 0703), Aalborg, North Denmark Sjaellands Universitetshospital Roskilde ( Site 0701), Roskilde, Region Sjælland Odense University Hospital ( Site 0705), Odense C, Region Syddanmark France
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0810), Nice, Alpes-Maritimes Centre Hospitalier Lyon-Sud ( Site 0804), Pierre-Bénite, Auvergne-Rhône-Alpes Institut Paoli-Calmettes ( Site 0803), Marseille, Bouches-du-Rhone Centre Hospitalier de Versailles ( Site 0809), Le Chesnay, Yvelines Hopital Saint Louis ( Site 0805), Paris Germany
Universitaetsklinikum Ulm. ( Site 0906), Ulm, Baden-Wurttemberg Universitaetsklinikum Koeln ( Site 0901), Cologne, North Rhine-Westphalia St. Marien-Krankenhaus Siegen ( Site 0914), Siegen, North Rhine-Westphalia Universitaetsklinikum Carl Gustav Carus ( Site 0902), Dresden, Saxony Hungary
Pecsi Tudomanyegyetem Altalanos Orvostudomanyi Kar ( Site 1202), Pécs, Baranya Debreceni Egyetem Klinikai Kozpont ( Site 1201), Debrecen, Hajdú-Bihar Szabolcs Szatmár Bereg Vármegyei Oktatókórház ( Site 1206), Nyíregyháza, Szabolcs-Szatmár-Bereg Orszagos Onkologiai Intezet ( Site 1200), Budapest Ireland
Beaumont Hospital ( Site 2900), Dublin University Hospital Limerick ( Site 2903), Limerick Israel
Ha Emek Medical Center ( Site 1305), Afula Soroka Medical Center ( Site 1307), Beersheba Rambam Medical Center ( Site 1301), Haifa Hadassah Ein Karem Jerusalem ( Site 1300), Jerusalem Chaim Sheba Medical Center ( Site 1302), Ramat Gan Kaplan Medical Center ( Site 1304), Rehovot Sourasky Medical Center ( Site 1303), Tel Aviv Italy
Istituto Tumori Giovanni Paolo II ( Site 1409), Bari A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1400), Bologna ASST Spedali Civili di Brescia ( Site 1408), Brescia IRCCS Ospedale San Raffaele ( Site 1402), Milan Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1403), Naples Fondazione IRCCS Policlinico San Matteo ( Site 1407), Pavia IRCCS - Arcispedale Santa Maria Nuova ( Site 1405), Reggio Emilia Policlinico Umberto I ( Site 1404), Roma Poland
Pratia MCM Krakow ( Site 1601), Krakow, Lesser Poland Voivodeship Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site 1606), Wroclaw, Lower Silesian Voivodeship Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1608), Warsaw, Masovian Voivodeship Szpital Wojewódzki w Opolu-Hematology Department ( Site 1607), Opole, Opole Voivodeship Szpitale Pomorskie Sp. z o.o. ( Site 1600), Gdynia, Pomeranian Voivodeship Romania
Spitalul Clinic Colțea ( Site 1805), Bucharest, Bucharest Ovidius Clinical Hospital ( Site 1804), Ovidiu, Constanța County Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 1802), Brasov Institutul Regional de Oncologie Iasi ( Site 1801), Iași South Korea
Severance Hospital Yonsei University Health System ( Site 2201), Seoul Samsung Medical Center ( Site 2200), Seoul Spain
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 2000), L'Hospitalet de Llobregat, Barcelona Hospital Universitario de Salamanca ( Site 2002), Salamanca, Castille and León CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2005), A Coruña, La Coruna Hospital General Universitario de Alicante ( Site 2007), Alicante Hospital Universitari Vall d'Hebron ( Site 2001), Barcelona Hospital Universitario 12 de Octubre ( Site 2003), Madrid Hospital Puerta de Hierro ( Site 2009), Madrid Switzerland
Inselspital Bern ( Site 2303), Bern, Canton of Bern Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 2302), Bellinzona, Canton Ticino Turkey (Türkiye)
Mega Medipol-Hematology ( Site 2406), Stanbul, Istanbul Ankara Universitesi Tip Fakultesi Cebeci Hastanesi ( Site 2400), Ankara VKV Amerikan Hastanesi ( Site 2403), Istanbul Sisli Florence Nightingale Hastanesi ( Site 2407), Istanbul Dokuz Eylül Üniversitesi-Hematology ( Site 2402), Izmir Ukraine
MNPE ClinCenter of Oncology,Hematology,Transplantology and Palliative Care of CherkasyRegCouncil ( Site 2509), Cherkassy, Cherkasy Oblast Communal non-profit enterprise "Regional clinical hospital o-Hematology Department ( Site 2510), Ivano-Frankivsk, Ivano-Frankivsk Oblast Instit. of Blood Transfusion Medicine of the National Academy ( Site 2506), Lviv, Lviv Oblast National Cancer Institute ( Site 2507), Kyiv United Kingdom
Bristol Haematology and Oncology Centre ( Site 2610), Bristol, Bristol, City of Nottingham University Hospitals NHS Trust. City Hospital Campus ( Site 2601), Nottingham, England GenesisCare - Windsor ( Site 2608), Windsor, England Sarah Cannon Research Institute UK ( Site 2612), London, London, City of GenesisCare - Oxford ( Site 2607), Oxford, Oxfordshire GenesisCare - Cambridge ( Site 2611), Newmarket, Suffolk The Royal Marsden NHS Foundation Trust. ( Site 2606), Sutton, Surrey The Christie NHS Foundation Trust ( Site 2602), Manchester The First Affiliated Hospital of Nanchang University ( Site 2815), Nanchang, Jiangxi
The First Hospital of Jilin University-Hematology ( Site 2803), Changchun, Jilin Fudan University Shanghai Cancer Center ( Site 2801), Shanghai, Shanghai Municipality Huashan Hospital, Fudan University ( Site 2821), Shanghai, Shanghai Municipality West China Hospital Sichuan University ( Site 2810), Chengdu, Sichuan Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Unio ( Site 2800), Tianjin, Tianjin Municipality The First Affiliated Hospital, Zhejiang University ( Site 2826), Hangzhou, Zhejiang